Literature DB >> 22950897

Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene.

Ivana Jeziskova, Filip Razga, Martina Toskova, Dana Dvorakova, Shira Timilsina, Jiri Mayer, Zdenek Racil.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22950897     DOI: 10.3109/10428194.2012.727414

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  5 in total

Review 1.  Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.

Authors:  Fabio Forghieri; Patrizia Comoli; Roberto Marasca; Leonardo Potenza; Mario Luppi
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

Review 2.  Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?

Authors:  Daniela Cilloni; Jessica Petiti; Valentina Rosso; Giacomo Andreani; Matteo Dragani; Carmen Fava; Giuseppe Saglio
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

Review 3.  Strategies for minimal residual disease detection: current perspectives.

Authors:  Giacomo Andreani; Daniela Cilloni
Journal:  Blood Lymphat Cancer       Date:  2019-02-12

4.  Novel multiplex bead-based assay for detection of IDH1 and IDH2 mutations in myeloid malignancies.

Authors:  Velizar Shivarov; Milena Ivanova; Evgueniy Hadjiev; Elissaveta Naumova
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.752

5.  Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.

Authors:  Yann Ferret; Nicolas Boissel; Nathalie Helevaut; Jordan Madic; Olivier Nibourel; Alice Marceau-Renaut; Maxime Bucci; Sandrine Geffroy; Karine Celli-Lebras; Sylvie Castaigne; Xavier Thomas; Christine Terré; Hervé Dombret; Claude Preudhomme; Aline Renneville
Journal:  Haematologica       Date:  2018-02-22       Impact factor: 11.047

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.